Clinical Study
Anticoagulation Strategies in Venovenous Hemodialysis in Critically Ill Patients: A Five-Year Evaluation in a Surgical Intensive Care Unit
Table 2
Anticoagulation strategies and vascular access for renal replacement therapy.
| | Anticoagulation strategy, (%) | Vascular access, (%) |
| | CVVHD_Heparin | 3593 (33.8) | Femoral vein | 4604 (43.3) | | Genius_Heparin | 3543 (33.3) | Right sided jugular vein | 2149 (20.2) | | CVVHD_Citrate | 2956 (27.8) | Left sided jugular vein | 1663 (15.6) | | Genius_Citrate | 75 (0.7) | Right sided subclavian vein | 959 (9.0) | | CVVDH_Argatroban | 156 (1.5) | Left sided subclavian vein | 1098 (10.3) | | Genius_Argatroban | 230 (2.2) | Not documented or another vascular access | 170 (1.6) | | CVVHD_without anticoagulation | 90 (0.8) | | |
|
|
